The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Integration of high‐risk human papillomavirus: a key event in cervical carcinogenesis?
Abstract
An important occurrence in cervical carcinogenesis is deregulated expression of the high‐risk human papillomavirus (HR‐HPV) oncogenes E6 and E7. Several risk factors for cervical neoplastic progression are likely to contribute to viral oncogene deregulation, particularly integration of HR‐HPV into the host genome. Integration represents a by‐product of viral infection that is detected in almost 90% of cervical carcinomas. The mechanism of integration is not fully understood, although there is a clear predilection for chromosomal common fragile sites, most likely due to their accessibility for insertion of foreign DNA. Recent work has suggested that an important intermediate stage in cervical carcinogenesis is characterized by transcriptionally silent HR‐HPV integrants, which co‐exist with viral episomes in infected cells. As episome‐derived E2 protein inhibits integrant transcription, clearance of episomes (eg by host innate immunity) is associated with loss of integrant silencing and integrant selection. The process of integration and subsequent clonal selection of integrants can therefore be considered as two independent and biologically distinct events. Indeed, integrated HPV may be viewed as selectable because it represents a form of the virus that is resistant to host mechanisms of viral clearance, enabling infected cells to maintain viral oncogene expression and avoid cell death. Care should be taken in interpreting studies of HPV integration frequency in clinical samples, as the techniques used have assessed either the presence of integrated viral DNA or evidence of transcriptional activity from integrants, but not both. Copyright © 2007 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
The causal relation between human papillomavirus and cervical cancer
Bosch, F. X., Lorincz, A., Munoz, N., Meijer, C. J. L. M., & Shah, K. V. (2002) · Journal of Clinical Pathology · doi:10.1136/jcp.55.4.244 · Cited by 3,538
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., Shan, K. V., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.11.796 · Cited by 3,370
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells
Schwarz, E., Freese, U. K., Gissmann, L., Mayer, W., Roggenbuck, B., Stremlau, A., & Hausen, H. Z. (1985) · Nature · doi:10.1038/314111a0 · Cited by 1,483
NATURAL HISTORY OF CERVICAL INTRAEPITHELIAL NEOPLASIA
RICHART, R. M. (1967) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-196712000-00002 · Cited by 1,376
Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis
Hausen, H. Z. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.9.690 · Cited by 1,298
Natural History of Cervical Intraepithelial Neoplasia: A Critical Review
Östör, A. G. (1993) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199304000-00018 · Cited by 1,260
Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., & Klingelhutz, A. J. (1998) · Nature · doi:10.1038/23962 · Cited by 1,206 · cited 1×
“activated by E6 [26], HR-HPV integration is also an efficient way to activate telomerase and, through cooperative effects with E7, to immortalize epithelial cells [27,28].”
BackgroundThe natural history of cervical HPV infection: unresolved issues
Woodman, C. B. J., Collins, S. I., & Young, L. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2050 · Cited by 1,033
Mechanisms of human papillomavirus-induced oncogenesis
Münger, K., Baldwin, A., Edwards, K. M., Hayakawa, H., Nguyen, C. L., Owens, M., Grace, M., & Huh, K. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.11451-11460.2004 · Cited by 815
Telomerase activation by the E6 gene product of human papillomavirus type 16
Klingelhutz, A. J., Foster, S. A., & McDougall, J. K. (1996) · Nature · doi:10.1038/380079a0 · Cited by 660
Natural History of Dysplasia of the Uterine Cervix
Holowaty, P., Miller, A. B., Rohan, T., & To, T. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.3.252 · Cited by 608
Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.
Yee, C., Krishnan-Hewlett, I., Baker, C. C., et al. (1985) · PubMed · Cited by 607
Jeon, S., Allen-Hoffmann, B. L., & Lambert, P. F. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2989-2997.1995 · Cited by 582
Ronco, L. V., Karpova, A. Y., Vidal, M., & Howley, P. M. (1998) · Genes & Development · doi:10.1101/gad.12.13.2061 · Cited by 544
Jeon, S., & Lambert, P. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1654 · Cited by 527
The Physical State of Human Papillomavirus Type 16 DNA in Benign and Malignant Genital Tumours
Durst, M., Kleinheinz, A., Hotz, M., & Gissmann, L. (1985) · Journal of General Virology · doi:10.1099/0022-1317-66-7-1515 · Cited by 477
Cullen, A. P., Reid, R., Campion, M., & Lörincz, A. T. (1991) · Journal of Virology · doi:10.1128/jvi.65.2.606-612.1991 · Cited by 445
Seaweeds and ulcerative colitis in laboratory animals.
Marcus, R., & Watt, J. (1969) · The Lancet · doi:10.1016/s0140-6736(69)90187-1 · Cited by 427
Human papillomavirus type 16 and 18 gene expression in cervical neoplasias
Stoler, M. H., Rhodes, C. R., Whitbeck, A., Wolinsky, S. M., Chow, L. T., & Broker, T. R. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90232-r · Cited by 409
Klaes, R., Woerner, S. M., Ridder, R., Wentzensen, N., Duerst, M., Schneider, A., Lotz, B., Melsheimer, P., & Doeberitz, M. V. K. (1999) · PubMed · Cited by 407
Duensing, S. M., & Münger, K. (2002) · PubMed · Cited by 391
Peitsaro, P., Johansson, B., & Syrjänen, S. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.3.886-891.2002 · Cited by 390
Nees, M., Geoghegan, J. M., Hyman, T., Frank, S., Miller, L., & Woodworth, C. D. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4283-4296.2001 · Cited by 387
Jones, D. L., Alani, R. M., & Münger, K. (1997) · Genes & Development · doi:10.1101/gad.11.16.2101 · Cited by 378
Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential
Stanley, M. A. (2002) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2002.01151.x · Cited by 377
Remmink, A. J., Walboomers, J. M. M., Helmerhorst, T. J. M., Voorhorst, F. J., Rozendaal, L., Risse, E. K. J., Meijer, C. J. L. M., & Kenemans, P. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610305 · Cited by 368
Wentzensen, N., Vinokurova, S., & Doeberitz, M. V. K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0009 · Cited by 368
Cheng, S., Schmidt-Grimminger, D. C., Murant, T., Broker, T. R., & Chow, L. T. (1995) · Genes & Development · doi:10.1101/gad.9.19.2335 · Cited by 349
Chang, Y. E., & Laimins, L. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.9.4174-4182.2000 · Cited by 284
Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation
Bedell, M. A., Hudson, J. B., Golub, T. R., Turyk, M. E., Hosken, M., Wilbanks, G. D., & Laimins, L. A. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2254-2260.1991 · Cited by 274
Romanczuk, H., Thierry, F., & Howley, P. M. (1990) · Journal of Virology · doi:10.1128/jvi.64.6.2849-2859.1990 · Cited by 267
Properties of a non‐tumorigenic human cervical keratinocyte cell line
Stanley, M. A., Browne, H. M., Appleby, M., & Minson, A. C. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430422 · Cited by 267
INTRACELLULAR SURVEILLANCE OF PERSISTING VIRAL INFECTIONS
Hausen, H. Z. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90360-0 · Cited by 260
Hudson, J. B., Bedell, M. A., McCance, D. J., & Laiminis, L. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.2.519-526.1990 · Cited by 258
Common fragile sites are preferential targets for HPV16 integrations in cervical tumors
Thorland, E. C., Myers, S. L., Gostout, B. S., & Smith, D. I. (2003) · Oncogene · doi:10.1038/sj.onc.1206170 · Cited by 248
Arias-Pulido, H., Peyton, C. L., Joste, N. E., Vargas, H., & Wheeler, C. M. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1755-1762.2006 · Cited by 241
Ferber, M. J., Montoya, D. P., Yu, C., Aderca, I., McGee, A., Thorland, E. C., Nagorney, D. M., Gostout, B. S., Burgart, L. J., Boix, L., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206528 · Cited by 238
Veldman, T., Horikawa, I., Barrett, J. C., & Schlegel, R. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4467-4472.2001 · Cited by 237
Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas
Dürst, M., Croce, C. M., Gissmann, L., Schwarz, E., & Huebner, K. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.4.1070 · Cited by 232
The Human Papillomavirus E7 Oncoprotein Abrogates Signaling Mediated by Interferon-α
Barnard, P., & McMillan, N. A. J. (1999) · Virology · doi:10.1006/viro.1999.9771 · Cited by 227
Bernard, B., Bailly, C., Lenoir, M.-C., Darmon, M. Y., Thierry, F., & Yaniv, M. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4317-4324.1989 · Cited by 222
Dürst, M., Glitz, D., Schneider, A., & zur Hausen, H. (1992) · Virology · doi:10.1016/0042-6822(92)90688-l · Cited by 220
Suppression of cellular proliferation by the papillomavirus E2 protein
Dowhanick, J. J., McBride, A. A., & Howley, P. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.12.7791-7799.1995 · Cited by 215
Choo, K., Pan, C., & Han, S. (1987) · Virology · doi:10.1016/0042-6822(87)90195-4 · Cited by 212
Pett, M. R., Alazawi, W. O. F., Roberts, I., Dowen, S., Smith, D. I., Stanley, M. A., & Coleman, N. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3214 · Cited by 204
Self-citationHudelist, G., Manavi, M., Pischinger, K. I. D., Watkins-Riedel, T., Singer, C. F., Kubista, E., & Czerwenka, K. F. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2003.11.035 · Cited by 201
Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma
Ferber, M. J., Thorland, E. C., Brink, A. A., Rapp, A. K., Phillips, L. A., McGovern, R., Gostout, B. S., Cheung, T. H., Chung, T. K. H., Fu, W. Y., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1207006 · Cited by 182
Hopman, A. H., Smedts, F., Dignef, W., Ummelen, M., Sonke, G., Mravunac, M., Vooijs, G. P., Speel, E. M., & Ramaekers, F. C. (2004) · The Journal of Pathology · doi:10.1002/path.1490 · Cited by 173
Ziegert, C., Wentzensen, N., Vinokurova, S., Kisseljov, F., Einenkel, J., Hoeckel, M., & von Knebel Doeberitz, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206629 · Cited by 167
Cooper, K., Herrington, C. S., Stickland, J. E., Evans, M. F., & McGee, J. O. (1991) · Journal of Clinical Pathology · doi:10.1136/jcp.44.12.990 · Cited by 166
Luft, F., Klaes, R., Nees, M., Dürst, M., Heilmann, V., Melsheimer, P., & Doeberitz, M. V. K. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200102)9999:9999<::aid-ijc1144>3.0.co;2-l · Cited by 166
Couturier, J., Sastre‐Garau, X., Schneider‐Maunoury, S., Labib, A., & Orth, G. (1991) · Journal of Virology · doi:10.1128/jvi.65.8.4534-4538.1991 · Cited by 165
Hwang, E. S., Riese, D. J., Settleman, J., Nilson, L. A., Honig, J., Flynn, S., & DiMaio, D. (1993) · Journal of Virology · doi:10.1128/jvi.67.7.3720-3729.1993 · Cited by 158
Pett, M. R., Herdman, M. T., Palmer, R. D., Yeo, G. S. H., Shivji, M. K. K., Stanley, M., & Coleman, N. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600078103 · Cited by 157
Self-citationDas, B. C., Sharma, J. K., Gopalakrishna, V., & Luthra, U. K. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-9-2327 · Cited by 156
Webster, K., Parish, J. L., Pandya, M. J., Stern, P. L., Clarke, A. R., & Gaston, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.87 · Cited by 151
Melsheimer, P., Vinokurova, S., Wentzensen, N., Bastert, G., & Doeberitz, M. V. K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0565 · Cited by 144
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Li, S., Moy, L. C., Pittman, N. S., Shue, G., Aufiero, B. M., Neufeld, E. J., LeLeiko, N. S., & Walsh, M. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7803 · Cited by 139
Wentzensen, N., Ridder, R., Klaes, R., Vinokurova, S., Schaefer, U., & Doeberitz, M. V. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205104 · Cited by 139
Clonal Selection for Transcriptionally Active Viral Oncogenes during Progression to Cancer
Tine, B. A. V., Kappes, J. C., Banerjee, N. S., Knops, J. F., Lai, L., Steenbergen, R. D. M., Meijer, C. J. L. M., Snijders, P. J. F., Chatis, P. A., Broker, T. R., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11172-11186.2004 · Cited by 138
Papillomavirus Research: From Natural History to Vaccines and Beyond
Davy, C. E. (2006) · Future Virology · doi:10.2217/17460794.1.4.423 · Cited by 138
YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity
O’Connor, M. J., Tan, S., Tan, C. H., & Bernard, H. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.6529-6539.1996 · Cited by 126
Griep, A. E., Herber, R., Jeon, S., Lohse, J. K., Dubielzig, R. R., & Lambert, P. F. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1373-1384.1993 · Cited by 124
Kulmala, S.-M. A., Syrjänen, S., Gyllensten, U. B., Петровна, Ш. И., Петровичев, Н. Н., Tosi, P., Syrjänen, K. J., & Johansson, B. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.024570 · Cited by 124
Doeberitz, M. V. K., Bauknecht, T., Bartsch, D., & Hausen, H. Z. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1411 · Cited by 124
Woodworth, C. D., Notario, V., & DiPaolo, J. A. (1990) · Journal of Virology · doi:10.1128/jvi.64.10.4767-4775.1990 · Cited by 123
Human Papillomavirus Type 16 E2 Protein Has No Effect on Transcription from Episomal Viral DNA
Bechtold, V., Beard, P., & Raj, K. (2003) · Journal of Virology · doi:10.1128/jvi.77.3.2021-2028.2003 · Cited by 119
Herdman, M. T., Pett, M. R., Roberts, I., Alazawi, W., Teschendorff, A. E., Zhang, X.-Y., Stanley, M., & Coleman, N. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl172 · Cited by 118
Self-citationPhysical State of HPV16 and Chromosomal Mapping of the Integrated Form in Cervical Carcinomas
Kalantari, M., Blennow, E., Hagmar, B., & Johansson, B. (2001) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200103000-00008 · Cited by 116
MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors
Peter, M., Rosty, C., Couturier, J., Radvanyi, F., Teshima, H., & Sastre-Garau, X. (2006) · Oncogene · doi:10.1038/sj.onc.1209625 · Cited by 114
Sherman, L., & Schlegel, R. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.3269-3279.1996 · Cited by 113
Chan, W., Chong, T., Bernard, H., & KIock, G. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.4.763 · Cited by 113
Analysis of HPV16, 18, 31, and 35 DNA in pre-invasive and invasive lesions of the uterine cervix.
Pirami, L., Giaché, V., & Becciolini, A. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.7.600 · Cited by 113
Lehn, H., Villa, L. L., Marziona, F., Hilgarth, M., Hg, H., & Sauer, G. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-1-187 · Cited by 108
Alazawi, W., Pett, M. R., Arch, B. N., Scott, L., Freeman, T. C., Stanley, M., & Coleman, N. (2002) · PubMed · Cited by 105
Self-citationExpression of HPV16 E6 or E7 increases integration of foreign DNA.
Kessis, T. D., Connolly, D. C., Hedrick, L., & Cho, K. R. (1996) · PubMed · Cited by 105
Papillomavirus Reviews: Current Research on Papillomaviruses
Lacey, C. J. (1996) · Medical Entomology and Zoology · Cited by 104
Wagatsuma, M., Hashimoto, K., & Matsukura, T. (1990) · Journal of Virology · doi:10.1128/jvi.64.2.813-821.1990 · Cited by 104
Dürst, M., Bosch, F. X., Glitz, D., Schneider, A., & Hausen, H. Z. (1991) · Journal of Virology · doi:10.1128/jvi.65.2.796-804.1991 · Cited by 103
The role of viral integration in the development of cervical cancer
Yu, T., Ferber, M. J., Cheung, T. H., Chung, T. K. H., Wong, Y. F., & Smith, D. I. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2004.08.021 · Cited by 102
The integration of HPV-18 DNA in cervical carcinoma.
Corden, S. A., Sant‐Cassia, L. J., Easton, A. J., & Morris, A. G. (1999) · Molecular Pathology · doi:10.1136/mp.52.5.275 · Cited by 102
Control of interferon signaling in human papillomavirus infection
Koromilas, A. E. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00023-x · Cited by 99
Nagao, S., Yoshinouchi, M., Miyagi, Y., Hongo, A., Kodama, J., Itoh, S., & Kudo, T. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.3.863-867.2002 · Cited by 91
Soto, U., Das, B. C., Lengert, M., Finzer, P., Hausen, H. Z., & Rösl, F. (1999) · Oncogene · doi:10.1038/sj.onc.1202765 · Cited by 87
Translational approaches to improving cervical screening
Baldwin, P., Laskey, R. A., & Coleman, N. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1010 · Cited by 85
Self-citationDaniel, B., Mukherjee, G., Seshadri, L., Vallikad, E., & Krishna, S. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-10-2589 · Cited by 80
Bosch, F. X., Schwarz, E., Boukamp, P., Fusenig, N. E., Bartsch, D., & Hausen, H. Z. (1990) · Journal of Virology · doi:10.1128/jvi.64.10.4743-4754.1990 · Cited by 78
Tonon, S. A., Picconi, M. A., Bos, P. D., Zinovich, J. B., Galuppo, J., Alonio, L. V., & Teyssie, A. R. (2001) · Journal of Clinical Virology · doi:10.1016/s1386-6532(01)00155-x · Cited by 77
Rösl, F., Lengert, M., Albrecht, J., Kleine, K., Zawatzky, R., Schraven, B. L., & Hausen, H. Z. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2142-2150.1994 · Cited by 76
Stünkel, W., Huang, Z.-H., Tan, S., O’Connor, M. J., & Bernard, H. (2000) · Journal of Virology · doi:10.1128/jvi.74.6.2489-2501.2000 · Cited by 71
Shirasawa, H., Tomita, Y., Kubota, K., KASAI, T., Sekiya, S., Takamizawa, H., & Simizu, B. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-9-2011 · Cited by 69
Human Papillomavirus E2 Down-regulates the Human Telomerase Reverse Transcriptase Promoter
Lee, D., Kim, H.-Z., Jeong, K. W., Shim, Y. S., Horikawa, I., Barrett, J. C., & Choe, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203706200 · Cited by 68
Popescu, N. C., & DiPaolo, J. A. (1990) · PubMed · Cited by 65
Host responses to pathogenic Salmonella infection.Preprint
Jones, B. D. (1997) · Genes & Development · doi:10.1101/gad.11.6.679 · Cited by 64
Ai, W., Toussaint, E., & Roman, A. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.4220-4229.1999 · Cited by 63
Study of viral integration of HPV-16 in young patients with LSIL
Gallo, G., Bibbo, M., Bagella, L., Zamparelli, A., Sanseverino, F., Giovagnoli, M. R., Vecchione, A., & Giordano, A. (2003) · Journal of Clinical Pathology · doi:10.1136/jcp.56.7.532 · Cited by 62
Jn, P., Zhao, W. M., Askins, K., Broker, T. R., & Chow, L. (1997) · PubMed · Cited by 60
The effects of interferon on the expression of human papillomavirus oncogenes
Kim, K. Y., Blatt, L. M., & Taylor, M. W. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-3-695 · Cited by 56
Long-Term Effect of Interferon on Keratinocytes That Maintain Human Papillomavirus Type 31
Chang, Y. E., Pena, L., Sen, G. C., Park, J. K., & Laimins, L. A. (2002) · Journal of Virology · doi:10.1128/jvi.76.17.8864-8874.2002 · Cited by 55
Interferons in human papillomavirus infections
Cirelli, R., & Tyring, S. K. (1994) · Antiviral Research · doi:10.1016/0166-3542(94)90067-1 · Cited by 41
Sibbet, G. J., & Campo, M. S. (1990) · Journal of General Virology · doi:10.1099/0022-1317-71-11-2699 · Cited by 39
Zhao, W. M., Noya, F., Chen, W., Townes, T. M., Chow, L. T., & Broker, T. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.6.5026-5033.1999 · Cited by 37
Matzner, I., Savelyeva, L., & Schwab, M. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00504-9 · Cited by 23
Conservation of HPV‐16 E6/E7 ORF sequences in a cervical carcinoma
Cone, R. W., Minson, A. C., Smith, M. R., & McDougall, J. K. (1992) · Journal of Medical Virology · doi:10.1002/jmv.1890370205 · Cited by 21
In situ analysis of the transcriptional activity of integrated viral DNA using tyramide-FISH.
Ba, V. T., Knops, J. F., Tr, B., Chow, L., & Moen, P. T. (2001) · PubMed · Cited by 19
(2000) · PubMed
Cited by
The Biology and Life-Cycle of Human Papillomaviruses
Doorbar, J., Quint, W., Banks, L., Bravo, I. G., Stoler, M., Broker, T. R., & Stanley, M. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.06.083 · Cited by 1,528
Historical review of the causes of cancer
Blackadar, C. B. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i1.54 · Cited by 389
Mechanism of Genomic Instability in Cells Infected with the High-Risk Human Papillomaviruses
Kadaja, M., Isok-Paas, H., Laos, T., Ustav, E., & Ustav, M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000397 · Cited by 173
Lazarczyk, M., Cassonnet, P., Pons, C., Jacob, Y., & Favre, M. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00033-08 · Cited by 131
Sanduja, S., Kaza, V., & Dixon, D. A. (2009) · Aging · doi:10.18632/aging.100086 · Cited by 65
Metadata
- Authors
- Pett, M., & Coleman, N.
- Venue
- The Journal of Pathology
- Publisher
- Wiley
- Published
- 2007-06-15
- Volume
- 212
- Issue
- 4
- Pages
- 356-367
- ISSN
- 0022-3417 (ISSN-L)
- 1096-9896
- OpenAlex
- W2089963048
- Cited by
- 451
- References
- 108
- FWCI
- 13.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.